Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Oct 28, 2026
Reporting period
Not applicable
Filed with the SEC
Oct 29, 2026
CFOOption exercise
Context
Classification
option exercise
Code M — exercise or conversion of a derivative security
Planned / mechanical clue
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001193125-26-438722
Filed / recorded
Oct 29, 2026, 10:46 PM UTC
Added to OQRO
Oct 29, 2026, 10:47 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
KESTRA MEDICAL TECHNOLOGIES, LTD.
Issuer CIK
1877184
Ticker
KMTS
Reporting person
Vaseem Mahboob
Relationship
Officer
Officer title
Chief Financial Officer
Security
Common Shares
Table
Non-derivative (Table I)
Transaction date
Oct 28, 2026
Transaction code
M
Shares / units
39,903
Price per share
$17.00
Acquired / disposed
Acquired (A)
Shares owned after
100,512
Ownership form
Direct
Amendment
No
Footnotes from the filing
This reported transaction is a scheduled exercise and sale pursuant to a Rule 10b5-1 trading plan adopted on November 5, 2025.
The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $30.0000 to $30.4300. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.
A Kestra Medical Technologies officer told the SEC about a plan to sell $427K of Kestra Medical Technologies shares around Nov 18, 2026. The shares were not acquired as compensation. That is a tiny part of all Kestra Medical Technologies shares.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.